Sep 19, 09:08
82% of moneycontrol users recommend buying Ajanta Pharma.
What's your call on Ajanta Pharma today?
Read 4 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3218.40||0.96||3240.00||2420.00||54,830.54|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|Scheme||No. of Shares|
|Franklin India Prima Fund (G)||52,290|
|SBI Pharma Fund (G)||44,718|
|Motilal Oswal MOSt Focused Multicap 35 Fund - Direct Plan (G)||22,650|
|Motilal Oswal MOSt Focused Multicap 35 Fund - Regular Plan (G)||20,553|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 975.00 44.44%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ajanta Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 6,093.90 crore.The company has reported a standalone sales of Rs 280.79 crore and a Net Profit of Rs 58.72 crore for the quarter ended Jun 2014.
The company management includes Mannalal B Agrawal - Chairman, Purushottam B Agrawal - Vice Chairman, Madhusudan B Agrawal - Vice Chairman, Yogesh M Agrawal - Managing Director, Rajesh M Agrawal - Joint Managing Director, Chandrakant M Khetan - Director, Anil Kumar - Director, K H Viswanathan - Director, Prabhakar Dalal - Additional Director, Anjana Grewal - Additional Director.
It is listed on the BSE with a BSE Code of 532331 and the NSE with an NSE Code of AJANTPHARM.
Its Registered office is at "Ajanta House", Charkop,,Kandivli (West) Mumbai,Maharashtra - 400067.
Their Registrars are Link Intime India Pvt. Ltd.